FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Doxorubicin Hydrochloride Injection
Status: Discontinuation
»Therapeutic Categories: Oncology; Pediatric

Fresenius Kabi USA, LLC (New 03/05/2020)

Company Contact Information:

Presentation Posting Date Related Information
2 mg/mL, 10 mL single-dose vial (NDC 63323-883-10) 03/05/2020 Product available. Check wholesalers for inventory or contact Customer Service to place a direct order. 10 mL will be discontinued when inventory is depleted.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English